Literature DB >> 7929284

Inhibition of protein synthesis in insect cells by baculovirus-expressed heme-regulated eIF-2 alpha kinase.

P J Chefalo1, J M Yang, K V Ramaiah, L Gehrke, J J Chen.   

Abstract

To study further the regulation of the heme-regulated eIF-2 alpha kinase (HRI), we have produced functional wild type HRI using the baculovirus expression system. The amount of recombinant HRI protein expressed in insect cells is approximately 10 times higher than levels in reticulocytes. Baculovirus-expressed HRI (BV-HRI) is indistinguishable from HRI purified from rabbit reticulocytes. It is active both as an autokinase and an eIF-2 alpha kinase. BV-HRI is regulated by heme in vitro as well as in intact insect cells. Coexpression of the wild type HRI with the inactive K199R HRI, S51A eIF-2 alpha, or interleukin-1 beta (IL-1 beta) results in diminished expression of these proteins. Expression of wild type HRI also results in severe inhibition of general protein synthesis in Sf9 cells when compared with cells expressing K199R HRI or IL-beta. In addition, the guanine nucleotide exchange activity of eIF-2B is suppressed in Sf9 cells expressing wild type HRI but not in cells expressing the K199R HRI or IL-1 beta. Furthermore, expression of wild type HRI is increased by coexpression with the nonphosphorylatable S51A eIF-2 alpha or by the addition of hemin, which inhibits HRI activity. These results provide evidence that translational regulation by phosphorylation of eIF-2 alpha and sequestration of eIF-2B can operate in insect cells.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7929284

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

Review 1.  Regulation of protein synthesis by the heme-regulated eIF2alpha kinase: relevance to anemias.

Authors:  Jane-Jane Chen
Journal:  Blood       Date:  2007-04-01       Impact factor: 22.113

2.  Translation initiation control by heme-regulated eukaryotic initiation factor 2alpha kinase in erythroid cells under cytoplasmic stresses.

Authors:  L Lu; A P Han; J J Chen
Journal:  Mol Cell Biol       Date:  2001-12       Impact factor: 4.272

3.  Heme-regulated eIF2alpha kinase (HRI) is required for translational regulation and survival of erythroid precursors in iron deficiency.

Authors:  A P Han; C Yu; L Lu; Y Fujiwara; C Browne; G Chin; M Fleming; P Leboulch; S H Orkin; J J Chen
Journal:  EMBO J       Date:  2001-12-03       Impact factor: 11.598

4.  Mutations at the Ser50 residue of translation factor eIF-2alpha dominantly affect developmental rate, body weight, and viability of Drosophila melanogaster.

Authors:  S Qu; S E Perlaky; E L Organ; D Crawford; D R Cavener
Journal:  Gene Expr       Date:  1997

5.  Phosphorylation of elongation factor-2 kinase on serine 499 by cAMP-dependent protein kinase induces Ca2+/calmodulin-independent activity.

Authors:  T A Diggle; T Subkhankulova; K S Lilley; N Shikotra; A E Willis; N T Redpath
Journal:  Biochem J       Date:  2001-02-01       Impact factor: 3.857

6.  Phosphorylation of eukaryotic initiation factor 2 by heme-regulated inhibitor kinase-related protein kinases in Schizosaccharomyces pombe is important for fesistance to environmental stresses.

Authors:  Ke Zhan; Krishna M Vattem; Bettina N Bauer; Thomas E Dever; Jane-Jane Chen; Ronald C Wek
Journal:  Mol Cell Biol       Date:  2002-10       Impact factor: 4.272

Review 7.  Immunity to viruses: learning from successful human vaccines.

Authors:  Bali Pulendran; Jason Z Oh; Helder I Nakaya; Rajesh Ravindran; Dmitri A Kazmin
Journal:  Immunol Rev       Date:  2013-09       Impact factor: 12.988

8.  Role of phosphorylation sites and the C2 domain in regulation of cytosolic phospholipase A2.

Authors:  M A Gijón; D M Spencer; A L Kaiser; C C Leslie
Journal:  J Cell Biol       Date:  1999-06-14       Impact factor: 10.539

9.  Functional Characterization of the Canine Heme-Regulated eIF2alpha Kinase: Regulation of Protein Synthesis.

Authors:  Kimon C Kanelakis; Jayashree Pyati; Pamela C Wagaman; Jui Chang Chuang; Young Yang; Nigel P Shankley
Journal:  Adv Hematol       Date:  2009-06-22
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.